American Diabetes Association, Grant/Award Number: 1-17-ICTS-059 Footnotes DISCLOSURE None declared
Using expired semaglutide is not recommended for many reasons, including: Reduced Effectiveness Medications have expiration dates on their labels that display the time frame they should be used by to ensure they maintain their full potency and are still safe to use
In clinical trials, adults who used Wegovy alongside diet and lifestyle changes lost an average of 1415% of their body weight over one year.* Individual results vary based on factors such as dosage, adherence, lifestyle habits, and overall health
Slow titration is the primary mitigation
Current status: Phase 3 trials (expected to continue through 2025-2026) FDA approval timeline: Likely 2026-2027 at the earliest What needs to happen first: Complete Phase 3 trials in larger populations Gather long-term safety data FDA review and approval process Manufacturing scale-up So while the results are exciting, we're still a few years away from retatrutide being available by prescription
A few lose more
